Efficacy of Antiplatelet Therapy in Myeloproliferative Diseases in Relation to Immature Platelets and Thrombosis
Clinical Laboratory · 2026 · 72 (03/2026)
DOI: 10.7754/clin.lab.2025.250535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Lenka Bultasova und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Thrombosis, Aspirin, Blood Platelets.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Bultasova, L., Slavik, L., Hajsmanova, Z., Lavickova, A., Sigutova, P., & Bradacova, P. (2026). Efficacy of Antiplatelet Therapy in Myeloproliferative Diseases in Relation to Immature Platelets and Thrombosis. Clinical Laboratory, 72(03/2026). https://doi.org/10.7754/clin.lab.2025.250535
Vancouver
Bultasova L, Slavik L, Hajsmanova Z, Lavickova A, Sigutova P, Bradacova P. Efficacy of Antiplatelet Therapy in Myeloproliferative Diseases in Relation to Immature Platelets and Thrombosis. Clinical Laboratory. 2026;72(03/2026). doi:10.7754/clin.lab.2025.250535
BibTeX
@article{Bultasova2026,
author = {Bultasova, Lenka and Slavik, Ludek and Hajsmanova, Zdenka and Lavickova, Alena and Sigutova, Pavla and Bradacova, Pavla},
title = {Efficacy of Antiplatelet Therapy in Myeloproliferative Diseases in Relation to Immature Platelets and Thrombosis},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {03/2026},
doi = {10.7754/clin.lab.2025.250535}
}
EUVIMED